PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26123P0034Exercise oy 4 — Nova Biomedical Corp

Nova Biomedical Corp holds $2.5M across 67 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 3 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Sep 30, 2027 PoP end — agencies typically plan 12–18 months ahead.

261-Network Contract Office 21 (36C261)

Awarding office

Nova Biomedical Corp

Recipient

Sep 30, 2027

PoP end

$64K

Obligated

$146K

Potential

334516

NAICS

6515

PSC

Unrestricted

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted

Contract number36C26123P0034

Also listed as36C261-23-P-0034

Agency261-Network Contract Office 21 (36C261)

Awarding office261-Network Contract Office 21 (36C261)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentNova Biomedical Corp

CAGE1JU03

UEILCFDHTGXB5J3

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6515

Place of performanceRENO NV

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

Related solicitation36C26123Q0020

PoP startOct 1, 2022

PoP end (current)Sep 30, 2027

Obligated$64K

Current value$146K

Potential value$146K

Exercise Oy 4 is a federal Unrestricted award for 261-Network Contract Office 21 (36C261) held by Nova Biomedical Corp. Estimated value $146K ($64K obligated). Current period of performance ends Sep 30, 2027. Last award drew 1 bidder. Place of performance: RENO NV. Related solicitation 36C26123Q0020.

Exercise oy 4. Latest action is a modification.

Recompete timing

Public

● Expiring in 348 days

Current PoP ends Sep 30, 2027 (348 days remaining). Agencies typically plan 12–18 months ahead — at 11.4 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 36C26123P0034? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Nova Biomedical Corp — $2.5M obligated across 67 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($2.5M) · all agencies · Top 4 shown (90%); remaining ~10% is other agencies.

Department of Veterans Affairs (VA)$750K · 30%Department of Defense (DOD)$703K · 28%Department of Health and Human Services (HHS)$529K · 21%Department of State (DOS)$257K · 10%

Open full company profile →

Related awards

Same incumbent

75F40126P00197

NOVA BIOPROFILE FLEX 2 OPERATIONAL PARTS AND COMPONENTS FOR THREE CURRENTLY OWNED NOVA BIO…

$131K

Sep 10, 2027

HT941023P0014

STATSTRIP GLUCOSE METER WITH 45 STATSTRIP GLUCOSE STRIPS DELIVERY.

$155K

Jan 17, 2028

1333ND24PNB640498

PURCHASE OF MAMMALIAN CELL CULTURE METABOLITE AND CELL COUNT ANALYSIS SYSTEM WITH EXTENDED…

$150K

Apr 10, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26123P0034?

36C26123P0034 (Exercise oy 4) is a 261-Network Contract Office 21 (36C261) award with a potential value of $146K, currently held by Nova Biomedical Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C261-23-P-0034?

36C261-23-P-0034 is the dashed form of PIID 36C26123P0034 (Exercise oy 4), held by Nova Biomedical Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26123P0034?

261-Network Contract Office 21 (36C261) awarded 36C26123P0034 to Nova Biomedical Corp (potential $146K).

Who is the incumbent on 36C26123P0034?

Nova Biomedical Corp is the incumbent with $2.5M across 67 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2027.

When does Nova Biomedical Corp’s 36C26123P0034 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C26123P0034? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Oct 1, 2026